GILD Gilead Sciences, Inc.
$134.36
▼ 1.42%
57
Value
52
P/E19.61
61
P/B7.38
43
P/S5.66
44
EV/EBITDA14.25
58
Growth
61
Revenue Growth2.4%
34
EPS Growth1700.0%
100
FCF Growth-8.2%
43
Momentum
59
12-Month Return37.2%
75
3-Month Return-10.1%
44
1-Month Return-5.1%
44
RSI (14)42.63
50
50/200 MABullish
75
Profitability
65
ROE41.0%
59
ROA14.4%
74
Gross Margin80.8%
66
Operating Margin37.4%
73
Net Margin28.9%
71
FCF Yield5.7%
50
Risk
49
Beta0.33
35
60-Day Volatility25.2%
62
The QScore of 57 for Gilead Sciences indicates a neutral outlook, with the stock scoring high on profitability due to its strong ROE of 41.0% and operating margin of 37.4%. The growth category also supports the score, driven by a notable EPS growth of 1700.0%. However, the value category scores lower, as the stock trades at a P/E of 19.6 and P/B of 7.4, and the risk category is also a drawback due to its 60-day volatility of 25.2%. The long-term and short-term scores are aligned, suggesting a consistent view of the stock's prospects.